Why Rigel Pharmaceuticals, Inc. (RIGL) stock fell 13.3% on Friday, November 6, 2026

Rigel Pharmaceuticals, Inc. (RIGL) closed at $39.65, down 13.26% on Friday, November 6, 2026, on volume of 758,983 shares (3.0× its 3-month average); market value about $700.0M.

What happened: primary sources

Events Nexqual found for RIGL on Friday, November 6, 2026 or the trading day before (November 5, 2026):

• Nov 5, 2026: Reported Q3 2026 results: EPS $0.65 vs consensus $0.96 (miss), revenue $80.9M vs consensus $80.1M (beat). Guidance: Full year 2026 total revenues of approximately $290 to $295 million. source
• Nov 6, 2026: Cantor Fitzgerald: Target raised, Neutral, price target $43 → $47

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on RIGL

RIGL stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: RIGL results, November 5, 2026. Other big moves that day: November 6, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:31 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:31 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt